Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant Enterobacteriaceae (CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CRE-positive swab, with a median time to CRE colonization of 13 days (interquartile range, 7 to 21 days). Patients colonized with carbapenemase-producing CRE were more likely than those colonized with non-carbapenemase-producing CRE to develop CRE infections during their hospitalizations (36% versus 3%; P 0.05).
CITATION STYLE
Tamma, P. D., Kazmi, A., Bergman, Y., Goodman, K. E., Ekunseitan, E., Amoah, J., & Simner, P. J. (2019). The likelihood of developing a carbapenem-resistant Enterobacteriaceae infection during a hospital stay. Antimicrobial Agents and Chemotherapy, 63(8). https://doi.org/10.1128/AAC.00757-19
Mendeley helps you to discover research relevant for your work.